www.karger.com/cop This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License (www.karger.com/OA-license), applicable to the online version of the article only. Distribution for non-commercial purposes only

Asukata, Yuri

Hayashi, Kiyofumi

Ishigatsubo, Yoshiaki

Ishihara, Mami

Mizuki, Nobuhisa

Nakamura, Satoshi

Nishida, Tomomi

Shibuya, Etsuko

Takeno, Mitsuhiro

Case Reports in Ophthalmology

English

PubMed

Purpose: Patients with Behçet’s disease often need intraocular surgeries for the treatment of secondary cataract or glaucoma. This study aims to report the clinical course before and after the intraocular surgeries of 5 patients who were systematically treated with infliximab. Methods: Retrospective case series. Results: Seven eyes of 5 male patients with Behçet’s disease, who underwent intraocular surgery while under systemic infliximab therapy at Yokohama City University Hospital from 2007 to 2009, were included in the study. The mean age at surgery was 44.2 years. Phacoemulsification was performed on 4 eyes, and trabeculectomy was done on the remaining 3 eyes. The mean duration since the onset of the ocular symptoms was 107 months. Control of the ocular attacks with the use of other systemic medications was difficult for all patients; however, the use of infliximab enabled adequate control of the attacks. The visual acuity status during the preoperative stage did not worsen during the postoperative period. No infectious complication was observed in all cases. Conclusions: Our results suggest that infliximab treatment does not complicate any subsequent intraocular surgery. Patients with Behçet’s disease in need of intraocular surgery can benefit from control of attacks with infliximab treatment

Tomomi Nishida

Etsuko Shibuya

Yuri Asukata

Satoshi Nakamura

Mami Ishihara

Kiyofumi Hayashi

Mitsuhiro Takeno

Yoshiaki Ishigatsubo

Nobuhisa Mizuki

Directory of Open Access Journals

Clinical Course before and after Cataract and Glaucoma Surgery under Systemic Infliximab Therapy in Patients with Behçet’s Disease

Crossref

S. Karger Ag

Tomomi Nishidaa

B Etsuko Shibuyab Yuri Asukatab

Satoshi Nakamurab

Mami Ishiharab

Kiyofumi Hayashib

Mitsuhiro Takenoc

Yoshiaki Ishigatsuboc

Nobuhisa Mizukib

CiteSeerX

Al-Arfaj A: Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behçet’s disease.

Cataract surgery under infliximab therapy in a patient with Behçet’s disease.

Clinical factors related to the efficacy and complications of orthopedic surgery for rheumatoid arthritis with infliximab.

Heiligenhaus A: Prevalence of uveitic secondary glaucoma and success of nonsurgical treatment in adults and children in a tertiary referral center. Ocul Immunol Inflamm

Inaba G: Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet’s disease with refractory uveoretinitis.

Rashid S: Management of coincident cataract and uveitis.

Tsuneoka H: Intraocular surgery in patients receiving infliximab therapy for Behçet disease.

Clinical Course before and after Cataract and Glaucoma Surgery under Systemic Infliximab Therapy in Patients with Behçet's Disease

Clinical Course before and after Cataract and Glaucoma Surgery under Systemic Infliximab Therapy in Patients with Behçet's Disease

Abstract

Similar works

Full text

Available Versions

Directory of Open Access Journals

Crossref

CiteSeerX